We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Volume 42 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 33 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 22 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Keep up to date with the UK policy development in respect of Standard Essential Patents.
How to assess household and non-household packaging from 2024 onwards if you’re a UK organisation affected by extended producer responsibility (EPR) for packaging.
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Sustainable food system indicators for the UK.
Operational plans and summaries 2013
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Find out how to work out your annual alcohol production if you’re part of a group, or you merge with, or separate from another business.
View the permits issued by the Environment Agency under the Industrial Emissions Directive
Statistics on MOD expenditure with industry, broken down by both region and industry group.
Progress reports on open Ministry of Defence websites which include metrics providing usage, accessibility and satisfaction ratings data.
Statistics on direct and indirect employment as a result of MOD expenditure with UK industry and commerce.
Your company must meet the independence criteria to provide data storage or anti-tamper devices to the tobacco industry.
Use a separate statement of objection form for each Japanese GI product name you object to.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.